What is a multidisciplinary tumor board and should my Endometrial Cancer case be presented

Understanding Multidisciplinary Tumor Boards for Endometrial Cancer

What Is a Multidisciplinary Tumor Board?

A multidisciplinary tumor board (often called a "tumor board" or "case conference") is a team of cancer specialists from different medical fields who meet regularly to review and discuss individual patient cases. The goal is to develop the most comprehensive and personalized treatment recommendations.

Who's on the Team?

A typical endometrial cancer tumor board includes:

• Medical Oncologists (chemotherapy specialists)
• Gynecologic Oncologists (surgeons specializing in women's cancers)
• Radiation Oncologists (radiation therapy specialists)
• Pathologists (specialists who analyze tissue samples)
• Radiologists (imaging specialists)
• Nurses and other support staff

How They Work Together

Each specialist brings their expertise to the discussion. For example:

• The pathologist explains what type of endometrial cancer you have and any important biomarkers
• The surgeon discusses surgical options and what was found during surgery
• The medical oncologist considers chemotherapy options
• The radiation oncologist evaluates whether radiation therapy might help
• Together, they develop a coordinated treatment plan

---

Should Your Endometrial Cancer Case Be Presented?

Yes, presenting your case to a multidisciplinary tumor board is generally recommended for endometrial cancer.

Why This Matters for Endometrial Cancer

According to NCCN (National Comprehensive Cancer Network) Guidelines for Endometrial Cancer, multidisciplinary review is particularly important because:

1. Endometrial cancer has different types and risk levels - Your specific type (Type 1 vs. Type 2, grade, stage) significantly affects treatment decisions
2. Treatment options vary widely - Depending on your cancer characteristics, you might benefit from surgery alone, surgery plus chemotherapy, surgery plus radiation, or combinations
3. Biomarkers are increasingly important - Testing for specific mutations (like MMR deficiency, MSI-high status, or POLE mutations) can guide treatment choices
4. Coordinated care improves outcomes - Research shows that cases reviewed by multidisciplinary teams tend to have better treatment planning

Important Context About Tumor Boards

However, it's important to understand a limitation: Research shows that when the same molecular test results are sent to different tumor boards, there's only 44-63% agreement on treatment recommendations (according to Cancer Patient Lab webinar discussions on precision oncology). This means tumor boards are valuable, but they're not perfect—they involve expert judgment that can vary.

---

Questions to Ask Your Oncology Team

To ensure your case gets appropriate multidisciplinary review:

1. "Will my case be presented to a multidisciplinary tumor board?" - Some hospitals do this routinely; others do it upon request.

2. "What specialists will review my case, and what information will they have?" - Make sure your pathology report, imaging results, and surgical findings are included.

3. "How will the tumor board's recommendations be communicated to me?" - Ask how you'll receive the results and whether you can discuss them with your primary oncologist.

4. "Are there any molecular tests (like MMR, MSI, or POLE testing) that should be done before the tumor board review?" - These biomarkers increasingly influence endometrial cancer treatment decisions.

5. "If I want a second opinion, how can I facilitate that?" - Some patients benefit from having their case reviewed at another cancer center.

---

Key Takeaway

A multidisciplinary tumor board review is a best practice for endometrial cancer care and can help ensure you receive coordinated, comprehensive treatment planning. Don't hesitate to ask your healthcare team whether your case will be presented—it's a reasonable request that demonstrates your engagement in your care.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.